Middle East and Africa Surgical Sealants and Adhesives Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

Middle East and Africa Surgical Sealants and Adhesives Market Size

• The Middle East and Africa Surgical Sealants and Adhesives Market size was valued at USD 28.66 billion in 2025 and is expected to reach USD 50.93 billion by 2033, at a CAGR of 7.45% during the forecast period
• The market growth is largely fueled by the increasing number of surgical procedures worldwide and the rising adoption of advanced wound closure solutions, leading to greater utilization of surgical sealants and adhesives across hospitals and specialty clinics
• Furthermore, growing demand for minimally invasive surgeries and faster patient recovery is establishing surgical sealants and adhesives as essential alternatives to traditional sutures and staples. These converging factors are accelerating the adoption of efficient haemostasis and tissue sealing solutions, thereby significantly boosting the market growth

Middle East and Africa Surgical Sealants and Adhesives Market Analysis

• Surgical sealants and adhesives, designed to provide effective haemostasis, tissue bonding, and wound closure, are becoming critical components in modern surgical practices across various specialties due to their ability to reduce surgical time and improve patient outcomes
• The increasing demand for these products is primarily driven by the rising prevalence of chronic diseases requiring surgical intervention, continuous advancements in biomaterials, and a growing preference for minimally invasive and patient-friendly surgical techniques
• Saudi Arabia dominated the Middle East and Africa Surgical Sealants and Adhesives Market in 2025, due to the country’s expanding healthcare infrastructure, increasing number of surgical procedures, and rising demand for advanced wound closure solutions in hospitals and specialty clinics
• U.A.E. is expected to be the fastest growing region in the Middle East and Africa Surgical Sealants and Adhesives Market during the forecast period due to rising demand for advanced surgical technologies and strong growth in private healthcare infrastructure
• Synthetic and semisynthetic sealants and adhesives segment dominated the market with a market share of 62.9% in 2025, due to their superior mechanical strength, longer durability, and broader applicability across complex surgical procedures. These products offer consistent performance, faster setting times, and enhanced bonding capabilities, making them highly suitable for high-pressure environments such as cardiovascular and orthopedic surgeries. Their scalability in manufacturing and longer shelf life further support their widespread adoption in hospitals and surgical centers

Report Scope and Middle East and Africa Surgical Sealants and Adhesives Market Segmentation

Middle East and Africa Surgical Sealants and Adhesives Market Trends

“Rising Adoption of Advanced and Biocompatible Surgical Sealants”

• A significant trend in the Middle East and Africa Surgical Sealants and Adhesives Market is the increasing adoption of advanced and biocompatible materials designed to enhance surgical outcomes and reduce post-operative complications across multiple medical specialties. These materials are improving tissue compatibility and enabling more efficient wound closure compared to traditional methods, strengthening their role in modern surgical practices
• For instance, Baxter International Inc. offers fibrin-based sealants such as Tisseel that are widely used for haemostasis and tissue sealing in complex surgical procedures. Such products demonstrate the growing preference for biologically derived sealants that closely mimic natural healing processes and improve patient recovery outcomes
• The integration of synthetic polymer-based sealants with enhanced elasticity and adhesion strength is expanding their use in high-pressure surgical environments such as cardiovascular and pulmonary procedures. These innovations are improving reliability and reducing the risk of leakage or complications during critical operations
• The increasing shift toward minimally invasive surgeries is accelerating the demand for sealants that can be applied quickly and effectively in confined surgical spaces. This is positioning advanced adhesives as essential tools for improving surgical precision and reducing operation time
• Healthcare providers are increasingly focusing on reducing hospital stays and enhancing patient comfort, which is driving the adoption of sealants that promote faster healing and minimize trauma. This trend is reinforcing the role of surgical adhesives in improving overall healthcare efficiency
• The market is witnessing continuous innovation in bioengineered and hybrid sealants that combine strength, flexibility, and safety. This rising adoption of advanced and biocompatible solutions is strengthening the transition toward more efficient, patient-centric surgical care globally

Middle East and Africa Surgical Sealants and Adhesives Market Dynamics

Driver

“Increasing Number of Surgical Procedures Globally”

• The increasing volume of surgical procedures worldwide is driving the demand for surgical sealants and adhesives, as healthcare systems expand to address rising cases of chronic diseases and trauma-related conditions. These products are becoming essential in supporting efficient wound closure and reducing surgical complications across diverse procedures
• For instance, Johnson & Johnson through its Ethicon division provides products such as SURGICEL and EVICEL that are widely used for haemostasis and sealing during surgeries. These solutions support surgeons in improving procedural efficiency and managing bleeding effectively in both routine and complex operations
• The rising prevalence of cardiovascular diseases, orthopedic conditions, and cancer is increasing the number of surgical interventions, thereby strengthening the demand for advanced sealing and adhesion technologies. This growing surgical burden is creating sustained opportunities for market expansion
• Advancements in surgical techniques and the growing adoption of minimally invasive procedures are further driving the use of sealants that enhance precision and reduce recovery time. These developments are reinforcing their importance in modern operating environments
• The continuous rise in surgical cases and the need for improved clinical outcomes are reinforcing this driver. The growing reliance on efficient and reliable wound closure solutions is positioning surgical sealants and adhesives as critical components in global healthcare systems

Restraint/Challenge

“High Cost and Regulatory Challenges Associated with Surgical Sealants”

• The Middle East and Africa Surgical Sealants and Adhesives Market faces challenges due to the high cost of advanced products and the stringent regulatory requirements associated with their approval and commercialization. These factors increase the overall financial burden on healthcare providers and limit widespread adoption in cost-sensitive regions
• For instance, U.S. Food and Drug Administration imposes rigorous approval processes for surgical sealants to ensure safety and efficacy, requiring extensive clinical testing and compliance with strict regulatory standards. These requirements extend product development timelines and increase costs for manufacturers
• The high price of biologically derived and advanced synthetic sealants makes them less accessible for smaller healthcare facilities and developing markets. This cost barrier restricts adoption despite their clinical advantages in improving surgical outcomes
• Manufacturers face complexities in maintaining consistent product quality and meeting evolving regulatory standards across different regions. These challenges add to operational costs and create barriers for new market entrants
• The combination of high costs and strict regulatory frameworks continues to restrain market growth. Addressing these challenges remains critical for expanding accessibility and ensuring broader adoption of surgical sealants and adhesives globally

Middle East and Africa Surgical Sealants and Adhesives Market Scope

The market is segmented on the basis of product, indication, and application.

• By Product

On the basis of product, the Middle East and Africa Surgical Sealants and Adhesives Market is segmented into natural/biological sealants and adhesives and synthetic and semisynthetic sealants and adhesives. The synthetic and semisynthetic sealants and adhesives segment dominated the market with the largest market revenue share of 62.9% in 2025, driven by their superior mechanical strength, longer durability, and broader applicability across complex surgical procedures. These products offer consistent performance, faster setting times, and enhanced bonding capabilities, making them highly suitable for high-pressure environments such as cardiovascular and orthopedic surgeries. Their scalability in manufacturing and longer shelf life further support their widespread adoption in hospitals and surgical centers. In addition, continuous advancements in polymer-based technologies and improved biocompatibility have strengthened their preference among surgeons seeking reliable and efficient wound closure solutions.

The natural/biological sealants and adhesives segment is anticipated to witness the fastest growth rate from 2026 to 2033, fueled by increasing demand for biocompatible and minimally invasive surgical solutions. These sealants, often derived from fibrin and collagen, closely mimic the body’s natural healing processes, reducing the risk of adverse reactions and promoting faster recovery. Growing awareness regarding patient safety and the shift toward regenerative medicine are accelerating their adoption in delicate procedures. Their effectiveness in reducing blood loss and improving healing outcomes further enhances their clinical value. Rising investments in biologics and advancements in bioengineered materials are expected to support sustained growth of this segment.

• By Indication

On the basis of indication, the Middle East and Africa Surgical Sealants and Adhesives Market is segmented into surgical haemostasis, tissue sealing, and tissue engineering. The tissue sealing segment dominated the market with the largest market revenue share in 2025, driven by its extensive use in preventing leakage of air and fluids across a wide range of surgical procedures. Tissue sealants are critical in ensuring secure closure, particularly in lung, gastrointestinal, and vascular surgeries where leakage can lead to severe complications. Their ability to reduce post-operative complications and shorten hospital stays has significantly increased their adoption. In addition, the growing volume of surgeries globally and advancements in surgical techniques have reinforced their importance in modern operating rooms. Continuous innovation in sealant formulations with enhanced adhesion and flexibility is further strengthening segment dominance.

The tissue engineering segment is anticipated to witness the fastest growth rate from 2026 to 2033, fueled by rapid advancements in regenerative medicine and biomaterials. Surgical adhesives are increasingly being used as scaffolding materials to support cell growth and tissue regeneration, particularly in complex reconstructive procedures. The rising focus on personalized medicine and advanced wound healing solutions is driving demand in this segment. Their role in improving functional recovery and reducing the need for repeat surgeries is gaining attention among healthcare providers. Increasing research activities and collaborations in bioengineering are expected to accelerate the adoption of sealants in tissue engineering applications.

• By Application

On the basis of application, the Middle East and Africa Surgical Sealants and Adhesives Market is segmented into central nervous system (CNS) surgeries, general surgeries, cardiovascular surgeries, orthopaedic surgeries, cosmetic surgeries, ophthalmic surgeries, urological surgeries, pulmonary surgeries, and other applications. The cardiovascular surgeries segment dominated the market with the largest market revenue share in 2025, driven by the critical need for effective haemostasis and secure tissue bonding in high-risk procedures. Surgical sealants play a vital role in preventing blood leakage and ensuring structural integrity in vascular and cardiac operations. The increasing prevalence of cardiovascular diseases and the rising number of complex surgical interventions have significantly boosted demand in this segment. In addition, the growing adoption of minimally invasive cardiac procedures has further increased the reliance on advanced sealants. Continuous innovation in high-performance adhesives tailored for cardiovascular applications is strengthening segment growth.

The central nervous system (CNS) surgeries segment is anticipated to witness the fastest growth rate from 2026 to 2033, fueled by the increasing complexity of neurosurgical procedures and the need for precise and reliable sealing solutions. Sealants are widely used to prevent cerebrospinal fluid leakage, which is critical for patient recovery and reducing post-operative complications. Advancements in neurotechnology and increasing incidence of neurological disorders are driving the demand for specialized surgical adhesives. Their ability to provide watertight closure and support delicate tissue structures enhances their clinical significance. Growing investments in neurosurgery infrastructure and innovation in biocompatible materials are expected to propel segment growth.

Middle East and Africa Surgical Sealants and Adhesives Market Regional Analysis

• Saudi Arabia dominated the Middle East and Africa Surgical Sealants and Adhesives Market with the largest revenue share in 2025, driven by the country’s expanding healthcare infrastructure, increasing number of surgical procedures, and rising demand for advanced wound closure solutions in hospitals and specialty clinics
• Growing investments in healthcare facilities, rising prevalence of chronic diseases requiring surgical intervention, and increasing adoption of minimally invasive procedures continue to strengthen the demand for surgical sealants and adhesives across the country
• The presence of advanced hospitals, increasing government focus on healthcare modernization, and rising participation of global medical device companies reinforce Saudi Arabia’s leadership position in the regional market

U.A.E. Middle East and Africa Surgical Sealants and Adhesives Market Insight

The U.A.E. is projected to record the fastest CAGR in the Middle East and Africa Surgical Sealants and Adhesives Market from 2026 to 2033, supported by rising demand for advanced surgical technologies and strong growth in private healthcare infrastructure. The country is witnessing increasing adoption of minimally invasive and cosmetic procedures that require efficient haemostasis and tissue sealing solutions. Expansion of multispecialty hospitals and medical tourism is accelerating the demand for high-performance surgical adhesives. Healthcare providers are focusing on improving surgical outcomes and reducing recovery time through advanced biomaterials. These developments position the U.A.E. as the fastest-growing market for surgical sealants and adhesives in the region.

South Africa Middle East and Africa Surgical Sealants and Adhesives Market Insight

South Africa is expected to witness steady growth between 2026 and 2033, driven by expanding healthcare services and increasing demand for effective surgical support products across public and private hospitals. Rising incidence of trauma cases and chronic diseases is supporting consistent demand for surgical procedures requiring sealants and adhesives. The growing adoption of modern surgical techniques and improved access to healthcare facilities is further encouraging product usage. Medical device suppliers are strengthening distribution networks to ensure product availability across urban and semi-urban regions. Continued focus on improving patient outcomes and surgical efficiency is contributing to stable long-term growth in South Africa’s Middle East and Africa Surgical Sealants and Adhesives Market.

Middle East and Africa Surgical Sealants and Adhesives Market Share

The surgical sealants and adhesives industry is primarily led by well-established companies, including:

• Baxter (U.S.)
• Johnson & Johnson Services, Inc. (U.S.)
• BD (U.S.)
• Medtronic (Ireland)
• Sanofi (France)
• B. Braun SE (Germany)
• Vivostat A/S (Denmark)
• Advanced Medical Solutions Group plc (U.K.)
• Cardinal Health (U.S.)
• Integra LifeSciences Corporation (U.S.)
• Mallinckrodt (Ireland)
• Grünenthal (Germany)
• Takeda Pharmaceutical Company Limited (Japan)
• Medline Industries, Inc. (U.S.)
• H.B. Fuller Medical Adhesive Technologies, LLC (U.S.)
• CSL (Australia)
• Stryker (U.S.)

Latest Developments in Middle East and Africa Surgical Sealants and Adhesives Market

• In August 2024, Resivant Medical received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its first product offerings, the Cutiva Topical Skin Adhesive and the Cutiva PLUS Skin Closure System, marking a significant regulatory milestone for the company’s entry into the Middle East and Africa Surgical Sealants and Adhesives Market. The Cutiva PLUS system uniquely integrates an adhesive mesh patch with a high-viscosity liquid adhesive, enabling improved wound closure strength and enhanced distribution of adhesive across the incision site. This combination approach helps in reducing wound tension and minimizing the risk of dehiscence, particularly in high-movement areas of the body. The clearance supports broader clinical adoption and highlights the growing focus on hybrid wound closure technologies that improve efficiency and patient outcomes
• In March 2024, TELA Bio, Inc. introduced the LIQUIFIX FIX8 Laparoscopic and LIQUIFIX Precision Open Hernia Mesh Fixation Devices in the U.S., representing a notable advancement in surgical fixation techniques. These devices are designed as adhesive-based solutions that allow surgeons to affix hernia mesh without penetrating patient tissue, which reduces trauma and potential complications associated with traditional fixation methods such as sutures or tacks. The innovation enhances procedural efficiency while improving patient comfort and recovery time. This development reflects a broader industry shift toward atraumatic and minimally invasive surgical solutions that prioritize safety and long-term performance
• In November 2023, Ethicon, a division of Johnson & Johnson MedTech, launched Ethizia, a hemostatic sealing patch developed to control bleeding during surgical procedures with greater precision and reliability. The product is designed to provide rapid haemostasis while also offering sealing capabilities, making it suitable for complex surgeries where bleeding control is critical. Its advanced material composition enables strong adherence to tissue even in challenging surgical environments. The launch strengthens Ethicon’s portfolio in surgical adjuncts and demonstrates the increasing demand for multifunctional products that combine haemostatic and sealing properties in a single solution
• In November 2023, Pramand LLC introduced the CraniSeal Dural Sealant System to the U.S. market, specifically developed for use in cranial surgeries where preventing cerebrospinal fluid leakage is essential. The system is engineered to provide a watertight seal over dural closures, enhancing surgical outcomes and reducing the risk of post-operative complications. Its formulation supports flexibility and compatibility with delicate neural tissues, which is critical in neurosurgical applications. This introduction reflects growing innovation in specialized sealants tailored for high-precision surgical fields such as neurology and spinal procedures
• In March 2023, Animus Surgical unveiled a new transparent, biodegradable, and non-toxic hydrogel wound sealant, advancing the capabilities of modern wound management solutions. The hydrogel formulation offers excellent visibility for surgeons during application while maintaining strong adhesion and flexibility. Its biodegradable and biocompatible nature reduces the need for removal and minimizes adverse reactions, supporting faster healing. The development highlights increasing focus on environmentally friendly and patient-safe materials in surgical care. This innovation aligns with the industry’s trend toward next-generation sealants that combine performance, safety, and sustainability in clinical applications

SKU-16644